FDA-cleared profile

CLEARREAD +CONFIRM

RIVERAIN TECHNOLOGIES · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.

Clinical role
Post-processing image enhancement for adjunctive line, tube, and electrical-cardiac-wire confirmation and localization.
Images and patients
X-ray/Radiography · Chest, including lines, tubes, and electrical cardiac wires
Key limitation
Keep in mind: The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest, including lines, tubes, and electrical cardiac wires Input: AP or PA chest radiographs from patients with lines and tubes; the device is not intended for pediatric patients.
  • Who uses it?Intended users: Trained professionals such as physicians, radiologists, and technicians
  • What does the software produce?Output: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
  • What is its most important limitation?Key limitation: The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.

Clinical takeaway. Clinical role: Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.

Evidence takeaway. Evidence from the reviewed source record: Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Generation of an enhanced secondary chest radiograph to facilitate confirmation and localization of lines and tubes; adjunctive information, not a substitute for the original image.
  • Exact FDA submission
  • Checked 2026-09-09
Workflow role
Post-processing image enhancement for adjunctive line, tube, and electrical-cardiac-wire confirmation and localization.
  • Exact FDA submission
  • Checked 2026-09-09
Required input
AP or PA chest radiographs from patients with lines and tubes; the device is not intended for pediatric patients.
  • Exact FDA submission
  • Checked 2026-09-09
Output and clinician action
An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.
  • Exact FDA submission
  • Checked 2026-09-09
Care setting
Adult
  • Exact FDA submission
  • Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Intended users
Trained professionals such as physicians, radiologists, and technicians
  • Exact FDA submission
  • Checked 2026-09-09
Limitations
The enhanced image is not a substitute for the original AP/PA image and provides adjunctive rather than diagnostic information. It is not intended for pediatric patients and is limited to chest radiographs of patients with lines and tubes; the packet does not establish a sensitivity or specificity endpoint.
  • Exact FDA submission
  • Checked 2026-09-09
Evidence summary
Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.
  • Exact FDA submission
  • Checked 2026-09-09

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Functional verification and development validation tested the software against design requirements. A multi-reader, multi-case clinical validation measured radiologist time to localize tube, line, and electrical cardiac-wire tips and localization accuracy; ClearRead +Confirm significantly decreased read times with and without outliers, while differences from true locations were not statistically significant. No numeric sensitivity, specificity, or AUC endpoint is reported.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

ClearRead +Confirm regulatory performance study summary

  • DesignReader Study
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K123526
  • IndependenceIndependence not established

K123526

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K123526. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: AP or PA chest radiographs from patients with lines and tubes; the device is not intended for pediatric patients.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-09 · FDA K123526: CLEARREAD +CONFIRM

  2. Routing

    Source context, not route validation: The device shares a DICOM communication and system-configuration platform with ClearRead Bone Suppression and supports review, storage, printing, and distribution of DICOM-compliant images across hospital networks. A specific PACS/RIS interface or deployment model is not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-09 · FDA K123526: CLEARREAD +CONFIRM

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-09 ·

  4. Returned objects

    Source context, not route validation: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-09 · FDA K123526: CLEARREAD +CONFIRM

  5. Viewer/worklist/report

    Unresolved route: An enhanced secondary digital AP/PA chest radiographic image with improved visibility of lines and tubes, including tube, line, and electrical cardiac-wire tips, for adjunctive confirmation; the original image remains required.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-09 · FDA K123526: CLEARREAD +CONFIRM

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Integration
The device shares a DICOM communication and system-configuration platform with ClearRead Bone Suppression and supports review, storage, printing, and distribution of DICOM-compliant images across hospital networks. A specific PACS/RIS interface or deployment model is not established.
  • Exact FDA submission
  • Checked 2026-09-09
Training
The 510(k) summary states the ClearRead +Confirm device is intended to be used by trained professionals, such as physicians, radiologists, and technicians, on patients with lines and tubes, and is not intended for pediatric patients.
  • Exact FDA submission
  • Checked 2026-10-27

User qualification wording only; the summary specifies no training program or training offering for this device.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for CLEARREAD +CONFIRM; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K123526
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Anatomy
Chest, including lines, tubes, and electrical cardiac wires
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2012-12-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K123526 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Deployment: Not verified - checked 2026-09-09 - Exact FDA submission

    The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-09 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K123526: CLEARREAD +CONFIRM

    U.S. Food and Drug Administration - Published 2012-12-27 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. ClearRead +Confirm model card (K123526)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K123526

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

Research history

  1. K123526 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K231001

DeepTek CXR Analyzer v1.0

DeepTek Medical Imaging Pvt Ltd

Authorized purpose: Concurrent CADe support for identifying, categorizing, and highlighting suspicious regions of interest in the Lungs, Pleura, Cardiac, and Hardware categories on chest radiographs for radiologist review.

Modality
X-ray/Radiography
Anatomy
Chest: lungs, pleura, cardiac structures, and hardware
Decision
2023-10-05
FDA-cleared K231149

qXR-CTR

Qure.ai Technologies

Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.

Modality
X-ray/Radiography
Anatomy
Heart and thoracic cavity
Decision
2023-09-22
FDA-cleared K222036

MPXA-2000

Medipixel, Inc.

Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.

Modality
X-ray/Radiography
Anatomy
Coronary arteries and cardiovascular anatomy
Decision
2023-03-22

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history